Anixa’s Ovarian Cancer Trial Progress: Promising Results
Anixa Biosciences advances Phase 1 clinical trial for ovarian cancer therapy, increasing dosage and showing promising results. Market responds positively ...
- Latest
- Trending
Anixa Biosciences advances Phase 1 clinical trial for ovarian cancer therapy, increasing dosage and showing promising results. Market responds positively ...
Kintara Therapeutics has launched a clinical trial for REM-001, a promising treatment for cutaneous metastatic breast cancer. The trial aims ...
Gilead Sciences acquires CymaBay Therapeutics for $4.3 billion to expand its liver disease portfolio, including access to potential treatment for ...
Cidara Therapeutics receives $11.1 million milestone payment from Mundipharma for European approval of new antifungal drug, Rezzayo. Analysts see potential ...
AN2 Therapeutics voluntarily pauses enrollment in its epetraborole clinical trial due to lower efficacy. Safety is not a concern. The ...
Biopharmaceutical company Atossa Genetics receives Buy rating from H.C. Wainwright, with a new price target of $4.00. The company's promising ...
Sharp HealthCare is leading the way in bringing Apple's Vision Pro VR headset into healthcare. The high-resolution screens and advanced ...
The Federal Reserve is facing pressure to cut interest rates, but evidence suggests that its patience in delaying rate cuts ...
The global Assisted Reproductive Technology market is projected to grow by $8.23 billion by 2027, driven by rising infertility rates ...
The use of robotic-assisted surgery and surgical navigation techniques does not increase the risk of joint infection in total hip ...
We are building the future together with you. We write content with maximum speed and excellent quality. Each material is accompanied by an analyst's commentary.